false
Hamburger Menu
Catalog
On Demand: Targeting Cardiac Inflammation as an Ap ...
On Demand: Targeting Cardiac Inflammation as an Approach to CV Risk Reduction
Webinar Description
It is now recognized that beyond cholesterol storage issues, cardiac inflammation plays a critical role in the development and progression of atherosclerotic cardiovascular disease (ASCVD). In June 2023, the U.S. Food and Drug Administration approved the first anti-inflammatory cardiovascular treatment, indicating a reduction of myocardial infarction, stroke, coronary revascularization and cardiovascular death in adult patients with established ASCVD or multiple risk factors. Please click to view Dr. Canto's perspective on the opportunities with these new clinical developments.
Summary
Availability:
On-Demand
Cost:
FREE
Credit Offered:
No Credit Offered
×
On Demand: Targeting Cardiac Inflammation as an Approach to CV Risk Reduction Course List
Login
User Login
Continue with Google
OR
Email
Password
Logging In…
Forgot Password
×
Please select your language
1
English